Assessing quality of life in Alzheimer's disease: Implications for clinical trials

INTRODUCTION: Characterization of the quality of life (QOL) in Alzheimer's disease (AD) scale within the context of a clinical trial may inform its applicability in future trials. METHODS: Using data from 1322 patients enrolled in two phase-III studies (EXPEDITION 1 [NCT00905372] and 2 [NCT0090...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahle-Wrobleski, Kristin, Ye, Wenyu, Henley, David, Hake, Ann Marie, Siemers, Eric, Chen, Yun-Fei, Liu-Seifert, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312555/
https://www.ncbi.nlm.nih.gov/pubmed/28229126
http://dx.doi.org/10.1016/j.dadm.2016.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312555/
https://www.ncbi.nlm.nih.gov/pubmed/28229126
http://dx.doi.org/10.1016/j.dadm.2016.11.004

Ejemplares similares